Evidence review
5-Amino-1MQ Results: What to Realistically Expect (and What's Proven)
5-Amino-1MQ 'results' are anecdotal — every efficacy finding is from mice. No human trial exists, so any before-and-after is uncontrolled and diet-dependent.
Search "5-Amino-1MQ results" or "5-Amino-1MQ before and after," and you'll find transformation photos, forum logs, and clinic testimonials promising melted body fat and a faster metabolism in a capsule. It's worth being blunt about what those represent before you read another one: none of them is a result in the scientific sense. A genuine "result" is an outcome measured in a controlled trial, against a placebo, with diet and training held constant. Nothing like that exists for 5-Amino-1MQ in humans. What you're looking at is anecdote — and anecdote about a metabolic compound is among the least reliable evidence there is.
The honest headline: every efficacy finding for 5-Amino-1MQ comes from mice. There is not a single controlled human trial, so any human "result" you read is uncontrolled, unverified, and hopelessly confounded by whatever diet and training the person was also doing. That doesn't mean nobody loses weight while taking it — people do. It means you cannot credit the capsule for it. Hold that frame against every before-and-after you encounter.
What "Results" Actually Exist — and the Species They're In
The data that built 5-Amino-1MQ's reputation is real, and it deserves a fair hearing — it is just entirely rodent. 5-Amino-1MQ is a small-molecule inhibitor of the enzyme NNMT (nicotinamide N-methyltransferase), and the foundational finding came in 2014, when researchers showed that knocking down NNMT protected mice from diet-induced obesity, increasing energy expenditure and blunting high-fat-diet weight gain2. The follow-up that sellers point to most: in 2018, selective, membrane-permeable NNMT inhibitors in this chemical class reversed diet-induced obesity in mice, cutting fat mass in obese animals1.
These are legitimate results — in mice. And even the rodent work carries a caveat that the marketing skips: later research showed the effect was entangled with diet, with a reduced-calorie diet combined with NNMT inhibition producing a distinct metabolic state3. In other words, even in the animals where it "works," the compound looked diet-dependent rather than a standalone fat-burner. There is no equivalent human result of any kind — no trial measuring fat loss, body composition, or metabolic rate in people.
Mouse evidence vs. human anecdote
| Mouse evidence (controlled studies) | Human 'results' (anecdote only) |
|---|---|
| NNMT knockdown protected mice from diet-induced obesity in a controlled lab setting (Kraus 2014). | No controlled human trial of any kind — fat loss, body composition, or metabolic rate has never been measured in people. |
| A small-molecule NNMT inhibitor in this class reversed obesity and reduced fat mass in obese mice (Neelakantan 2018). | Before-and-after photos exist but have no control group, so there is no way to know what would have happened without the compound. |
| Effect was diet-dependent — pairing a reduced-calorie diet with NNMT inhibition produced a distinct metabolic state (Dimet-Wiley 2022). | Testimonials are confounded by the diet and training people start at the same time; the deficit gets no credit, the capsule does. |
| Identity, dose, and purity were controlled in the animal studies. | Grey-market product is unverified, so the person reporting may not have taken what the label claimed — plus survivorship and placebo bias. |
Why Human "Before-and-Afters" Don't Prove Anything
Here is the uncomfortable mechanics of a 5-Amino-1MQ testimonial. Almost nobody takes it in isolation. People start it when they're already motivated — they've cleaned up their diet, started a deficit, picked up training, maybe added cardio. Then they lose fat, and the capsule gets the credit. That's not evidence; that's a textbook confound. The intervention that actually drove the result (eating less) is invisible in the photo, and the compound that didn't get tested takes the bow.
Layer on the usual distortions of online anecdote: no control group, so there's no way to know what would have happened without it. Survivorship bias, because people who lose weight post; people who don't, quietly stop. The placebo effect, which is powerful for anything you've paid for and expect to work. And the grey-market reality that the product itself is unverified, so even the person reporting may not have taken what the label claimed. None of this is unique to 5-Amino-1MQ — it's the same pattern we flag across our peptides for fat loss review, where striking mechanistic stories repeatedly fail to survive a controlled human test.
Realistic Expectations: What to Actually Set
So what should you expect? Honestly: assume nothing attributable to the compound, because nothing has been demonstrated. If 5-Amino-1MQ does anything in humans, the rodent and mechanistic picture suggests the most it could plausibly be is a modest, diet-dependent nudge to energy expenditure — not a transformation, and not a substitute for a calorie deficit. Even that is a hopeful extrapolation, not a measured effect.
The practical takeaway is unglamorous and true: the variable that determines your before-and-after is the deficit, not the capsule. A person in a sustained calorie deficit will lose fat whether or not they add 5-Amino-1MQ, and there is no human evidence that adding it accelerates that loss. If you're choosing it expecting a visible result the diet alone wouldn't produce, you're betting on a translation from mouse to human that has never been demonstrated and frequently fails. The numbers people quote about how they take it are themselves unvalidated folklore, which we break down in our 5-Amino-1MQ dosage page.
Before you trust a transformation photo
How to read 5-Amino-1MQ 'results' honestly
- There is no controlled human trial — every fat-loss 'result' is anecdotal, and the only measured efficacy is in mice.
- Testimonials are confounded: people start it while also dieting and training, so the deficit drives the loss and the capsule gets the credit.
- No control, plus survivorship bias (winners post, others quit quietly) and placebo effect — none of which a before-and-after can rule out.
- Grey-market product is unverified, so even the person reporting may not have taken what the label claimed.
- Set expectations to modest and diet-dependent at most — unproven in humans, and never a substitute for a calorie deficit.
Bottom Line
5-Amino-1MQ has real results — in mice. NNMT knockdown protected rodents from diet-induced obesity2, a small-molecule inhibitor in this class reversed obesity in obese mice1, and even that effect looked diet-dependent3. That is the entire evidence base, and it stops at the species line.
For humans, there are no results — only anecdotes, and anecdotes about a fat-loss compound are uniquely untrustworthy: uncontrolled, survivorship-biased, placebo-prone, and confounded by the diet and training people are doing alongside it. The before-and-afters are real photos of real fat loss; they just don't prove the capsule did it. Set your expectations accordingly: unproven in humans, modest and diet-dependent at most, and no replacement for a deficit. For the full mechanism and why the human evidence is missing, read our 5-Amino-1MQ evidence breakdown, the supply-and-legality reality in where to buy peptides and the research-chemical legality question, and the research tools we use to keep these claims honest.
Frequently asked questions
Are there real before-and-after results for 5-Amino-1MQ?
There are before-and-after photos and forum logs, but no scientific results. Every controlled efficacy finding for 5-Amino-1MQ is in mice — NNMT knockdown protected mice from diet-induced obesity (Kraus 2014) and a small-molecule inhibitor in this class reversed obesity in mice (Neelakantan 2018). No controlled human trial has ever measured fat loss or body composition in people, so any human before-and-after is anecdote, not evidence.
Why don't testimonials prove 5-Amino-1MQ works?
Because they're hopelessly confounded. Almost everyone who takes 5-Amino-1MQ is also dieting and training, so the calorie deficit drives the fat loss while the capsule gets the credit. Add no control group, survivorship bias (people who lose weight post; people who don't, quit quietly), and the placebo effect, and an online before-and-after simply cannot show the compound caused anything.
What results should I realistically expect from 5-Amino-1MQ?
Realistically, expect nothing attributable to the compound, because nothing has been demonstrated in humans. If it does anything, the rodent and mechanistic picture suggests at most a modest, diet-dependent nudge to energy expenditure — not a transformation. The variable that determines your before-and-after is the calorie deficit, not the capsule, and there's no human evidence that adding 5-Amino-1MQ speeds up fat loss.
Can 5-Amino-1MQ replace a calorie deficit for fat loss?
No. There is no human evidence that it produces fat loss at all, and even the mouse data was diet-dependent — pairing a reduced-calorie diet with NNMT inhibition produced the metabolic state, not the inhibitor alone (Dimet-Wiley 2022). A sustained calorie deficit is what drives fat loss; 5-Amino-1MQ is not a proven substitute for it.
Why are 5-Amino-1MQ results so unreliable compared to a drug?
Approved drugs earn their 'results' in controlled, placebo-comparison human trials. 5-Amino-1MQ has none — it's an unapproved grey-market research chemical with no human efficacy or safety study. So instead of trial data you get anecdotes, which are confounded by diet, biased by who chooses to post, distorted by placebo, and based on a product whose actual identity and dose are unverified.
References
- Neelakantan H, Vance V, et al. (2018). Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse diet-induced obesity in mice. Biochemical Pharmacology. https://pubmed.ncbi.nlm.nih.gov/29155147/
- Kraus D, Yang Q, et al. (2014). Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. https://pubmed.ncbi.nlm.nih.gov/24717514/
- Dimet-Wiley A, Wu Q, et al. (2022). Reduced calorie diet combined with NNMT inhibition establishes a distinct metabolic state. Scientific Reports. https://pubmed.ncbi.nlm.nih.gov/35013352/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
Peptides for Athletic Recovery: What the Evidence Shows
An evidence-based look at sermorelin and GH-secretagogue peptides for athletic recovery — what the research actually proves, and what it does not.
ReadDoes Sermorelin Help Athletes?
Does sermorelin help athletes? An honest, evidence-based answer: the GHRH(1-29) trial data and the GH-in-athletes meta-analysis say no proven benefit.
ReadGH Peptides and Recovery: The Real Evidence
GH and IGF-1 recovery physiology explained honestly: what the science shows about growth hormone, sleep, and muscle repair — and what it does not prove.
ReadAre GH Peptides Safe & Legal for Athletes?
WADA status, doping detection, and documented adverse effects of GH and GH-secretagogue peptides — an honest safety and legality guide for athletes.
ReadBPC-157 for Healing & Recovery: What the Evidence Actually Shows
BPC-157's healing claims rest almost entirely on rodent studies — no robust human trial exists. An honest, citation-first look at the evidence and the risks.
ReadTB-500 (Thymosin β4) for Recovery: What the Evidence Shows
TB-500's recovery claims rest on animal and lab studies of thymosin β4 — no robust human trial exists. An honest, citation-first evidence review.
ReadIpamorelin + CJC-1295: The Athlete's GH Stack, Examined
The ipamorelin + CJC-1295 stack reliably raises GH and IGF-1 — but no human trial shows it improves body composition or performance. An honest evidence review.
ReadPeptides for Muscle Growth: What Works vs Hype
GH-secretagogue peptides raise GH and IGF-1 — but human RCTs don't show added muscle or strength in healthy trained people. An honest, evidence-first review.
ReadBPC-157 + TB-500 Stack: What the Evidence Says About the Popular Recovery Combo
The BPC-157 + TB-500 "heal anything" stack is built on rodent data and anecdotes — no human trial tests the combo. An honest, citation-first evidence review.
ReadBPC-157 Dosage: What People Use (and What's Actually Unknown)
There is no FDA-validated BPC-157 dose. Common protocols are extrapolated from rat studies. An honest look at the numbers, the unknowns, and the risks.
ReadSermorelin for Muscle Growth & Bodybuilding: What the Evidence Says
Sermorelin raises your own growth hormone — but no human trial shows it builds muscle. An honest look at the dosing folklore, the proof gap, and the WADA ban.
ReadIpamorelin Side Effects: What the Evidence Actually Shows
Ipamorelin is sold as a 'clean' GH peptide, but its side-effect profile in humans is barely studied. An honest, citation-backed review of what's known.
ReadBest Peptides for Recovery & Healing: An Evidence Ranking
Which recovery peptides actually have human proof? An honest, citation-first ranking of BPC-157, TB-500, and GH peptides — where the evidence stops at rats.
ReadPeptides for Injury & Tendon Repair: What the Evidence Actually Shows
The tendon and injury claims for BPC-157, TB-500 and GH peptides are almost all animal data. An honest, citation-first look at what's proven in humans.
ReadThe "Wolverine Stack" (BPC-157 + TB-500), Examined
"Wolverine stack" is the viral nickname for BPC-157 + TB-500. We trace where the name came from, what marketers claim, and what the evidence actually shows.
ReadIGF-1 LR3: What the Evidence Shows
IGF-1 LR3 is a long-acting IGF-1 analog sold for muscle growth. Honest review: animal-only data, no human trials, WADA-banned, and a real cancer-signal caution.
ReadDoes Oral BPC-157 Work? Capsules vs Injection, Honestly
Oral BPC-157 capsules are everywhere. The gut data is genuinely oral; the recovery claims aren't. What the evidence actually supports — and what it doesn't.
ReadBPC-157 Before & After: What's Realistic vs. What's Marketing
There are no human before-and-after recovery trials of BPC-157 — it's preclinical only. What the rat studies show, why timelines are unknown, and the red flags.
ReadCJC-1295 With DAC vs No DAC (Mod GRF 1-29): The Real Difference
DAC makes CJC-1295 a multi-day GH "bleed"; no-DAC (Mod GRF 1-29) is a short pulse. What the one human PK study shows — and what it doesn't.
ReadMK-677 (Ibutamoren): What the Evidence Shows
MK-677 reliably raises GH and IGF-1, but the 1-year trial found no strength or function gain. Honest review: never FDA-approved, edema, glucose, WADA-banned.
ReadBPC-157 Nasal Spray: Does Intranasal Delivery Actually Work?
BPC-157 nasal sprays are sold for systemic recovery and "nose-to-brain" effects. There's no human PK showing either works. What the evidence really says.
ReadAOD-9604 for Fat Loss: Does the Evidence Hold Up?
AOD-9604 burned fat in obese mice but failed to beat placebo in its large human obesity trial. An honest, citation-first look at the fat-loss claims.
ReadGHK-Cu (Copper Peptide) for Recovery & Skin: The Evidence
GHK-Cu has real wound-healing and collagen science — but mostly topical and in-vitro. Injectable systemic-recovery claims are unproven. An honest review.
ReadMOTS-c: The "Exercise Mimetic" Peptide — Does It Work?
MOTS-c has striking rodent endurance and mitochondrial data — but zero human performance trials. An honest, citation-first evidence review.
ReadThymosin Alpha-1 for Athletes & Immune Support: The Evidence
Thymosin alpha-1 is a real immune-modulating drug in disease — but there is zero proven recovery or performance benefit for healthy athletes. An honest review.
ReadBPC-157 vs TB-500: Which Healing Peptide Is Better?
BPC-157 vs TB-500 compared honestly: local vs systemic action, mechanism, and evidence. Both rest on animal data, both are WADA-banned, neither is FDA-approved.
ReadPeptides vs SARMs for Recovery & Muscle: An Honest Comparison
Peptides and SARMs work via different mechanisms. SARMs carry real hormone and organ risks; both are unapproved and WADA-banned. An honest evidence comparison.
ReadHow to Reconstitute Peptides: Bacteriostatic Water, Step by Step
Research peptides ship as a freeze-dried powder you have to mix yourself. The concentration math, the water choice, and why none of it is medical advice.
ReadSubcutaneous vs. Intramuscular: How to Inject Peptides
Subq vs IM, needle gauge and angle, site rotation, and why 'inject near the injury' is mostly anecdote. A technique explainer — not medical advice.
ReadDo Peptides Show Up on Drug Tests? (WADA & Workplace)
Recovery peptides are invisible to standard workplace panels but detectable by WADA/USADA anti-doping assays — and contamination can trigger a positive.
ReadWhere to Buy Peptides & the "Research Chemical" Gray Zone
How the "research use only" loophole works, why grey-market peptides fail purity testing, and how to read a COA — an honest, evidence-first buying guide.
ReadBPC-157 for Tendonitis: Dosing, Timeline & Evidence
Rat Achilles studies are genuinely encouraging and the mechanism is plausible — but there are zero human tendinopathy trials. An honest, citation-first review.
ReadPeptides for Bone & Fracture Healing: What the Evidence Shows
One rabbit study had BPC-157 rivaling a bone graft — but there are zero human fracture trials and these peptides are WADA-banned. An honest, cited review.
ReadPeptides for Rotator Cuff & Shoulder Injuries: The Evidence
BPC-157 and TB-500 are marketed for rotator cuff tears. The animal data is real; human shoulder evidence is absent. An honest, citation-first review.
ReadPeptides for Knee Injuries (ACL, Meniscus, Cartilage)
BPC-157 is marketed for post-ACL recovery and meniscus tears. Honest review: knee ligament data is rat-only and human knee evidence is one weak case series.
ReadHow Long Does BPC-157 Take to Work?
Forums claim days. Honest answer: any fast effect is inflammation modulation, not healing — and every BPC-157 timeline is extrapolated from animal data.
ReadThe 2026 FDA Peptide Reclassification (BPC-157 & Co.): What It Actually Means
FDA removed BPC-157 from 503A Category 2 and set a July 2026 advisory review — but that is not approval. What the reclassification does and does not change.
ReadPeptides for Back Pain & Herniated Disc: What the Evidence Says
Can BPC-157 or TB-500 heal a herniated disc? No human disc-regeneration data exists, and peptides won't reverse a large extrusion. An honest evidence review.
ReadBPC-157 for Nerve Pain & Sciatica: What the Evidence Actually Shows
BPC-157's nerve-healing data come from rat sciatic-nerve studies — no human trial exists for sciatica or nerve pain. An honest, citation-first evidence review.
ReadPeptides for Plantar Fasciitis & Achilles: Any Evidence?
BPC-157 is marketed for plantar fasciitis and Achilles pain. Honest review: the angiogenesis mechanism is animal-only and there's zero human foot RCT.
ReadPeptides for Arthritis & Joint Pain (OA vs RA): The Evidence
BPC-157 is marketed for arthritis and joint pain. Honest review: only human data is one uncontrolled 16-patient knee case series; FDA-unapproved, WADA-banned.
ReadGHRP-2 vs GHRP-6 vs Hexarelin: How They Actually Differ
GHRP-2, GHRP-6 and hexarelin compared: real differences in appetite, selectivity and cardiac effects, but athletic benefit is unproven and all are WADA-banned.
ReadHGH Fragment 176-191: Fat-Loss Evidence or Hype?
HGH Fragment 176-191 burns fat in mice but has no human trials proving it works. An honest, citation-first look at the science behind the hype.
ReadTesamorelin for Athletes: What the Evidence Actually Shows
Tesamorelin is FDA-approved for HIV belly fat, not athletes. The performance case is off-label, WADA-banned, and unproven. An honest, citation-first review.
ReadKPV Peptide: The Anti-Inflammatory Tripeptide, Honestly Reviewed
KPV is an anti-inflammatory tripeptide with real mechanism and strong animal colitis data — but no human trials. An honest, citation-first review.
ReadMyostatin Inhibitors: Follistatin-344 & ACE-031
Myostatin inhibitors like ACE-031 and follistatin block a muscle-growth brake, but ACE-031 was halted for bleeding. An honest, evidence-first review.
ReadPeptide Cycling: How Long to Run, When to Break
The 4-6 week 'on,' weeks 'off' peptide cycling rules are anecdotal — no human trial set them. Here's the real mechanism behind them, and what's actually known.
ReadBPC-157 Cost: Research Vials vs Clinic Pricing (2026)
What BPC-157 actually costs in 2026 — research vials, telehealth, and clinics — and why the cheapest price is usually the biggest red flag.
ReadPeptide Vendor Red Flags: Warning Signs of a Scam Source
Fake timers, identical 99.9% purity claims, crypto-only checkout, COA dates that don't add up — a practical scam-detection checklist for peptide buyers.
ReadWADA 2026 Prohibited List: What Changed for Peptides
The 2026 WADA List added one peptide (pegmolesatide) and clarified GLP-1 monitoring — but GH peptides and BPC-157 were already banned. An honest read.
ReadSS-31 (Elamipretide): Mitochondrial Peptide for Endurance?
SS-31/elamipretide just earned its first FDA approval — for an ultra-rare disease. Aged-mouse endurance data is real; healthy-athlete trials are zero.
ReadRetatrutide for Athletes: Triple-Agonist Recomp Evidence (& WADA Status)
Retatrutide drove ~24% weight loss in a Phase 2 obesity trial — but it's not FDA-approved and is WADA-prohibited. An honest, citation-first read for athletes.
ReadHow to Verify a Peptide COA: Reading HPLC/MS & Spotting Fakes
What a real peptide COA must show — HPLC purity, MS identity, a matching lot number, a recent date — and how fake, recycled certificates give themselves away.
ReadPEG-MGF (Mechano Growth Factor): Satellite-Cell Evidence & Reality Check
PEG-MGF is a PEGylated IGF-1 splice variant sold for muscle growth. Honest review: satellite-cell data is preclinical-only, zero human trials, WADA-banned.
ReadDSIP Peptide: Does It Actually Improve Sleep and Recovery?
DSIP (delta sleep-inducing peptide) is sold for sleep and recovery. Honest review: decades-old, contradictory human data and no modern athletic trials.
ReadKisspeptin: What the Evidence Shows for Testosterone, Libido & PCT
Kisspeptin is sold to athletes for testosterone, libido, and post-cycle recovery. Honest review: real human endocrine data, but no proof it works as a PCT drug.
ReadPeptides for Fat Loss: What Actually Works vs Hype (Recomp Guide)
An honest, goal-routed guide to peptides for fat loss and recomp. What the evidence shows for each option, what's hype, and why the basics still win.
ReadSemax vs Selank: Focus vs Calm — What the Evidence Actually Shows
Semax vs Selank for athletes: focus and neuroprotection vs anxiety and stress. Honest comparison of two Russian nasal peptides built mostly on non-Western data.
Read5-Amino-1MQ: What the Evidence Shows for Fat Loss and Body Composition
5-Amino-1MQ is an NNMT inhibitor marketed for fat loss and NAD+. Honest review: the data is mouse-only — no human trials, not FDA-approved, grey-market.
Read5-Amino-1MQ Dosage: What the 'Protocols' Use and Why None Are Clinically Validated
There is no clinically validated human dose of 5-Amino-1MQ. The common 50–150 mg/day capsule 'protocols' are extrapolated from mouse studies, not trials.
Read5-Amino-1MQ Side Effects & Safety: An Honest Look at the Unknowns
Is 5-Amino-1MQ safe? The honest answer: nobody knows. There is essentially no human safety data — only mouse and cell studies. Here is what that means.
Read